Biology:Janus kinase 1

From HandWiki
Revision as of 06:18, 12 February 2024 by SpringEdit (talk | contribs) (link)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

JAK1 is a human tyrosine kinase protein essential for signaling for certain type I and type II cytokines. It interacts with the common gamma chain (γc) of type I cytokine receptors, to elicit signals from the IL-2 receptor family (e.g. IL-2R, IL-7R, IL-9R and IL-15R), the IL-4 receptor family (e.g. IL-4R and IL-13R), the gp130 receptor family (e.g. IL-6R, IL-11R, LIF-R, OSM-R, cardiotrophin-1 receptor (CT-1R), ciliary neurotrophic factor receptor (CNTF-R), neurotrophin-1 receptor (NNT-1R) and Leptin-R). It is also important for transducing a signal by type I (IFN-α/β) and type II (IFN-γ) interferons, and members of the IL-10 family via type II cytokine receptors.[1] Jak1 plays a critical role in initiating responses to multiple major cytokine receptor families. Loss of Jak1 is lethal in neonatal mice, possibly due to difficulties suckling.[2] Expression of JAK1 in cancer cells enables individual cells to contract, potentially allowing them to escape their tumor and metastasize to other parts of the body.[3]

Interactions

Janus kinase 1 has been shown to interact with:

See also

  • Janus kinase inhibitor

References

  1. "Signaling by type I and II cytokine receptors: ten years after". Curr. Opin. Immunol. 13 (3): 363–73. 2001. doi:10.1016/S0952-7915(00)00228-4. PMID 11406370. https://zenodo.org/record/1260155. 
  2. "Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses". Cell 93 (3): 373–83. 1998. doi:10.1016/S0092-8674(00)81166-6. PMID 9590172. 
  3. Christian Nordqvist. "Protein JAK Makes Cancer Cells Contract, So They Can Squeeze Out Of A Tumor". Medical News Today. http://www.medicalnewstoday.com/articles/232761.php. 
  4. "A Stat3-interacting protein (StIP1) regulates cytokine signal transduction". Proc. Natl. Acad. Sci. U.S.A. 97 (18): 10120–5. August 2000. doi:10.1073/pnas.170192197. PMID 10954736. Bibcode2000PNAS...9710120C. 
  5. "The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex". J. Immunol. 171 (6): 2989–94. September 2003. doi:10.4049/jimmunol.171.6.2989. PMID 12960323. 
  6. "Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction". J. Biol. Chem. 276 (40): 37451–8. October 2001. doi:10.1074/jbc.M106135200. PMID 11468294. 
  7. "Transmembrane domain of gp130 contributes to intracellular signal transduction in hepatic cells". J. Biol. Chem. 272 (49): 30741–7. December 1997. doi:10.1074/jbc.272.49.30741. PMID 9388212. 
  8. "Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation". Biochem. J. 361 (Pt 1): 105–11. January 2002. doi:10.1042/0264-6021:3610105. PMID 11742534. 
  9. "Through induction of juxtaposition and tyrosine kinase activity of Jak1, X-gene product of hepatitis B virus stimulates Ras and the transcriptional activation through AP-1, NF-kappaB, and SRE enhancers". Biochem. Biophys. Res. Commun. 286 (5): 886–94. September 2001. doi:10.1006/bbrc.2001.5496. PMID 11527382. 
  10. "Involvement of Janus kinases in the insulin signaling pathway". Eur. J. Biochem. 234 (2): 656–60. December 1995. doi:10.1111/j.1432-1033.1995.656_b.x. PMID 8536716. 
  11. 11.0 11.1 "Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors". J. Immunol. 169 (3): 1302–8. August 2002. doi:10.4049/jimmunol.169.3.1302. PMID 12133952. 
  12. "Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits". Science 266 (5187): 1045–7. November 1994. doi:10.1126/science.7973659. PMID 7973659. Bibcode1994Sci...266.1045M. 
  13. "Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID". Science 266 (5187): 1042–5. November 1994. doi:10.1126/science.7973658. PMID 7973658. Bibcode1994Sci...266.1042R. https://zenodo.org/record/1231239. 
  14. "Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta". J. Biol. Chem. 273 (17): 10719–25. April 1998. doi:10.1074/jbc.273.17.10719. PMID 9553136. 
  15. "Functional cooperation of the interleukin-2 receptor beta chain and Jak1 in phosphatidylinositol 3-kinase recruitment and phosphorylation". Mol. Cell. Biol. 18 (11): 6416–22. November 1998. doi:10.1128/mcb.18.11.6416. PMID 9774657. 
  16. "Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor". Endocrinology 139 (3): 884–93. March 1998. doi:10.1210/endo.139.3.5829. PMID 9492017. 
  17. "Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases". J. Biol. Chem. 270 (48): 28527–30. December 1995. doi:10.1074/jbc.270.48.28527. PMID 7499365. 
  18. "Contribution of the Box 1 and Box 2 motifs of cytokine receptors to Jak1 association and activation". J. Biol. Chem. 277 (50): 48220–6. December 2002. doi:10.1074/jbc.M205757200. PMID 12374810. 
  19. "Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases". J. Biol. Chem. 272 (2): 1032–7. January 1997. doi:10.1074/jbc.272.2.1032. PMID 8995399. 
  20. "SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130". J. Biol. Chem. 278 (1): 661–71. January 2003. doi:10.1074/jbc.M210552200. PMID 12403768. 
  21. "Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways". J. Biol. Chem. 275 (49): 38633–9. December 2000. doi:10.1074/jbc.M007849200. PMID 10993906. 
  22. "STAM2, a new member of the STAM family, binding to the Janus kinases". FEBS Lett. 477 (1–2): 55–61. July 2000. doi:10.1016/s0014-5793(00)01760-9. PMID 10899310. 
  23. "Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways". J. Biol. Chem. 277 (9): 7076–85. March 2002. doi:10.1074/jbc.M108255200. PMID 11751884. 
  24. "Constitutive activation of STAT transcription factors in acute myelogenous leukemia". Eur. J. Haematol. 67 (2): 63–71. August 2001. doi:10.1034/j.1600-0609.2001.t01-1-00385.x. PMID 11722592. 
  25. 25.0 25.1 "An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT". Oncogene 14 (7): 751–61. February 1997. doi:10.1038/sj.onc.1200907. PMID 9047382. 
  26. "Induction of Jak/STAT signaling by activation of the type 1 TNF receptor". J. Immunol. 160 (6): 2742–50. March 1998. doi:10.4049/jimmunol.160.6.2742. PMID 9510175. 
  27. "Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells". Cell Growth Differ. 13 (1): 13–8. January 2002. PMID 11801527. 

Further reading

External links